Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTel-Aviv Sourasky Medical Center

About this trial

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups.

This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups:

1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center. 2. The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year.

Interstitial lung disease with an FVC below 80% or a DLCO below 60%.

Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%.

Pulmonary arterial hypertension.

Disqualifiers

Uncontrolled comorbidity (e.g uncontrolled congestive heart failure)

Inability to operate the mobile application.

Without a mobile device or computer.

A hospitalization in the 2-months prior to randomization.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Tele-Rehabilitation

    Other intervention

    Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3. Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4. Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Tele-RehabilitationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Adherence to pulmonary rehabilitation Between the Study Groups

Adherence will be defined as initiation of pulmonary rehabilitation in 3 months from study inclusion and completion of at least 50% (12 sessions) of the program (regular/remote based on allocation) within 6 months from inclusion.

Time frame
Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.

Secondary outcomes

1

Safety of Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation

Any safety events occurring during the Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation sessions (intervention/control group accordingly) or at the following 48 hours after. Safety events will be reported by the physiotherapist or treating physicians and assessed at every follow-up phone call. Each presumed safety event will be evaluated by the research team to decide about relevance and causality to the TPR/PR. Rates of safety events will be compared between the groups and will also be reported descriptively. Severity of adverse events will be determined based on the WHO International Classification for Patient Safety, and classified into mild (where no or minimal intervention were required), moderate (requiring treatment or permanent or long-term harm or loss of function) and (severe resulted in shortening of life expectancy or major permanent or long-term harm or loss of function).

Time frame
Assessed from enrollment to 6 months following study initiation.
2

Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate

Initiation rate of tele-pulmonary rehabilitation / traditional pulmonary rehabilitation. This will be defined as completion of at least one TPR / PR session.

Time frame
Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.
3

Global Evaluation of Treatment Effectiveness (GETE) score

Patient satisfaction with the tele-pulmonary rehabilitation \\ traditional rehabilitation program assessed using the Global Evaluation of Treatment Effectiveness (GETE) scale. The GETE is a measure of perceived treatment effectiveness, with responses between 1 (Complete control of the disease following the treatment) to 5 (Worsening of the disease following the treatment).

Time frame
Will be asked by the clinical research coordinator via phone call after 6 months following study initiation.
4

Respiratory Symptoms Burden Assessed by CAAT

Will be evaluated using the tools CAAT (Chronic Airways Assessment Test) eight question questionnaire on respiratory symptoms, confidence, sleep, and energy. The result is a score between 0-40. The score will be compared between the study groups.

Time frame
Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tel-Aviv Sourasky Medical Center

Lead sponsor

Barzilai Medical Center

Collaborator

International Respiratory Coalition (IRC)

Collaborator